XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2018   252,362,841      
Beginning balance at Dec. 31, 2018 $ 735,938 $ 25 $ 1,055,046 $ (66) $ (319,067)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)   5,776,611      
Issuance of common stock 6,812   6,812    
Stock-based compensation expense 41,093   41,093    
Net loss (147,983)       (147,983)
Other comprehensive income 329     329  
Ending balance (in shares) at Jun. 29, 2019   258,139,452      
Ending balance at Jun. 29, 2019 625,544 $ 25 1,092,306 263 (467,050)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (10,645)   (10,645)    
Beginning balance (in shares) at Mar. 30, 2019   254,744,029      
Beginning balance at Mar. 30, 2019 671,813 $ 25 1,070,224 96 (398,532)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)   3,395,423      
Issuance of common stock 5,881   5,881    
Stock-based compensation expense 20,424   20,424    
Taxes related to net share settlement of restricted stock units (4,223)   (4,223)    
Net loss (68,518)       (68,518)
Other comprehensive income 167     167  
Ending balance (in shares) at Jun. 29, 2019   258,139,452      
Ending balance at Jun. 29, 2019 625,544 $ 25 1,092,306 263 (467,050)
Beginning balance (in shares) at Dec. 31, 2019   264,883,426      
Beginning balance at Dec. 31, 2019 487,263 $ 26 1,126,827 188 (639,778)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)   4,700,954      
Issuance of common stock 1,003   1,002    
Stock-based compensation expense 37,920   37,920    
Net loss (83,803)       (83,803)
Other comprehensive income 162     162  
Ending balance (in shares) at Jul. 04, 2020   269,584,380      
Ending balance at Jul. 04, 2020 430,316 $ 27 1,153,520 350 (723,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition (12,229)   (12,229)    
Beginning balance (in shares) at Apr. 04, 2020   266,806,999      
Beginning balance at Apr. 04, 2020 521,055 $ 26 1,140,280 233 (619,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock (in shares)   2,777,381      
Issuance of common stock 545 $ 1 544    
Stock-based compensation expense 19,057   19,057    
Taxes related to net share settlement of restricted stock units (6,361)   (6,361)    
Net loss (104,097)       (104,097)
Other comprehensive income 117     117  
Ending balance (in shares) at Jul. 04, 2020   269,584,380      
Ending balance at Jul. 04, 2020 $ 430,316 $ 27 $ 1,153,520 $ 350 $ (723,581)